{"id":"https://openalex.org/W4362425309","doi":"https://doi.org/10.1158/1078-0432.22437814.v1","title":"Supplementary Tables S1-S11 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma","display_name":"Supplementary Tables S1-S11 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362425309","doi":"https://doi.org/10.1158/1078-0432.22437814.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22437814.v1","doi":"https://doi.org/10.1158/1078-0432.22437814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22437814.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S11_from_Safety_and_Efficacy_of_Axicabtagene_Ciloleucel_versus_Standard_of_Care_in_Patients_65_Years_of_Age_or_Older_with_Relapsed_Refractory_Large_B-Cell_Lymphoma/22437814/1/files/39887215.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S11_from_Safety_and_Efficacy_of_Axicabtagene_Ciloleucel_versus_Standard_of_Care_in_Patients_65_Years_of_Age_or_Older_with_Relapsed_Refractory_Large_B-Cell_Lymphoma/22437814/1/files/39887215.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021496101","display_name":"Jason R. Westin","orcid":"https://orcid.org/0000-0002-1824-2337","observed_orcids":["https://orcid.org/0000-0002-1824-2337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason R. Westin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1824-2337","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021394406","display_name":"Frederick Lundry Locke","orcid":"https://orcid.org/0000-0001-9063-6691","observed_orcids":["https://orcid.org/0000-0001-9063-6691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick L. Locke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9063-6691","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102014552","display_name":"Michael John Dickinson","orcid":"https://orcid.org/0000-0002-1492-5966","observed_orcids":["https://orcid.org/0000-0002-1492-5966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Dickinson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1492-5966","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085514831","display_name":"Armin Ghobadi","orcid":"https://orcid.org/0000-0001-8848-8474","observed_orcids":["https://orcid.org/0000-0001-8848-8474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Armin Ghobadi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8848-8474","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002524955","display_name":"Mahmoud Elsawy","orcid":"https://orcid.org/0000-0001-9872-2471","observed_orcids":["https://orcid.org/0000-0001-9872-2471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahmoud Elsawy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9872-2471","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043125083","display_name":"Tom van Meerten","orcid":"https://orcid.org/0000-0002-5581-6950","observed_orcids":["https://orcid.org/0000-0002-5581-6950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom van Meerten","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5581-6950","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081926380","display_name":"David Bernard Miklos","orcid":"https://orcid.org/0000-0003-0717-4305","observed_orcids":["https://orcid.org/0000-0003-0717-4305"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Miklos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0717-4305","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013730166","display_name":"Matthew L. Ulrickson","orcid":"https://orcid.org/0000-0002-1458-7813","observed_orcids":["https://orcid.org/0000-0002-1458-7813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew L. Ulrickson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1458-7813","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082333371","display_name":"Miguel\u2010Angel Perales","orcid":"https://orcid.org/0000-0002-5910-4571","observed_orcids":["https://orcid.org/0000-0002-5910-4571"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel-Angel Perales","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5910-4571","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100688501","display_name":"Umar Farooq","orcid":"https://orcid.org/0000-0001-7891-9891","observed_orcids":["https://orcid.org/0000-0001-7891-9891","https://orcid.org/0009-0006-5071-4070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Umar Farooq","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7891-9891","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063994503","display_name":"Luciano Wannesson","orcid":"https://orcid.org/0000-0002-5902-0757","observed_orcids":["https://orcid.org/0000-0002-5902-0757"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luciano Wannesson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5902-0757","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008419917","display_name":"Lori Ann Leslie","orcid":"https://orcid.org/0000-0002-7265-4076","observed_orcids":["https://orcid.org/0000-0002-7265-4076"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lori Leslie","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7265-4076","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036293139","display_name":"Marie Jos\u00e9 Kersten","orcid":"https://orcid.org/0000-0002-8904-3802","observed_orcids":["https://orcid.org/0000-0002-8904-3802"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie Jos\u00e9 Kersten","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8904-3802","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037526878","display_name":"Caron Alyce Jacobson","orcid":"https://orcid.org/0000-0002-0180-0654","observed_orcids":["https://orcid.org/0000-0002-0180-0654"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caron A. Jacobson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0180-0654","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040412322","display_name":"John M. Pagel","orcid":"https://orcid.org/0000-0001-5745-8125","observed_orcids":["https://orcid.org/0000-0001-5745-8125","https://orcid.org/0000-0003-2875-4878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Pagel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5745-8125","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029448872","display_name":"Gerald Georg Wulf","orcid":"https://orcid.org/0000-0002-7669-3785","observed_orcids":["https://orcid.org/0000-0002-7669-3785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald Wulf","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7669-3785","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076892547","display_name":"Patrick B. Johnston","orcid":"https://orcid.org/0000-0002-3212-3510","observed_orcids":["https://orcid.org/0000-0002-3212-3510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Johnston","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3212-3510","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080153027","display_name":"Aaron P. Rapoport","orcid":"https://orcid.org/0000-0003-0043-3562","observed_orcids":["https://orcid.org/0000-0003-0043-3562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron P. Rapoport","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0043-3562","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077785229","display_name":"Linqiu Du","orcid":"https://orcid.org/0000-0002-1265-7363","observed_orcids":["https://orcid.org/0000-0002-1265-7363"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linqiu Du","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1265-7363","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064789111","display_name":"Saran Vardhanabhuti","orcid":"https://orcid.org/0000-0003-1558-2755","observed_orcids":["https://orcid.org/0000-0003-1558-2755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saran Vardhanabhuti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1558-2755","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037111172","display_name":"Simone Filosto","orcid":"https://orcid.org/0000-0002-7854-998X","observed_orcids":["https://orcid.org/0000-0002-7854-998X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simone Filosto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7854-998X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061376546","display_name":"Jina Shah","orcid":"https://orcid.org/0000-0002-1053-2508","observed_orcids":["https://orcid.org/0000-0002-1053-2508"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jina Shah","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1053-2508","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027316831","display_name":"Julia Thornton Snider","orcid":"https://orcid.org/0000-0003-0017-4863","observed_orcids":["https://orcid.org/0000-0003-0017-4863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia T. Snider","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0017-4863","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046261818","display_name":"Paul Cheng","orcid":"https://orcid.org/0000-0002-9436-7764","observed_orcids":["https://orcid.org/0000-0002-9436-7764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Cheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9436-7764","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019726727","display_name":"Christina To","orcid":"https://orcid.org/0000-0001-7164-8072","observed_orcids":["https://orcid.org/0000-0001-7164-8072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina To","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7164-8072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040504519","display_name":"Olalekan O. Oluwole","orcid":"https://orcid.org/0000-0001-8525-9641","observed_orcids":["https://orcid.org/0000-0001-8525-9641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olalekan O. Oluwole","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8525-9641","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077430940","display_name":"Anna Maria Sureda","orcid":"https://orcid.org/0000-0002-1238-6970","observed_orcids":["https://orcid.org/0000-0002-1238-6970"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Sureda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1238-6970","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-large-b-cell-lymphoma","display_name":"relapsed/refractory large B-cell lymphoma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.925000011920929},{"id":"https://openalex.org/keywords/zuma-7","display_name":"ZUMA-7","score":0.9229999780654907},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.8230000138282776},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9890000224113464},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.902999997138977},{"id":"https://openalex.org/keywords/neurological-events","display_name":"neurological events","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cytopenia","display_name":"cytopenia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.40400001406669617},{"id":"https://openalex.org/keywords/standard-of-care-comparison","display_name":"standard of care comparison","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8116552829742432},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6306906938552856},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6287705302238464},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4403522312641144},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4298093616962433},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.322487473487854},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.1992110311985016},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22437814.v1","doi":"https://doi.org/10.1158/1078-0432.22437814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22437814.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S11_from_Safety_and_Efficacy_of_Axicabtagene_Ciloleucel_versus_Standard_of_Care_in_Patients_65_Years_of_Age_or_Older_with_Relapsed_Refractory_Large_B-Cell_Lymphoma/22437814/1/files/39887215.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22437814","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S11_from_Safety_and_Efficacy_of_Axicabtagene_Ciloleucel_versus_Standard_of_Care_in_Patients_65_Years_of_Age_or_Older_with_Relapsed_Refractory_Large_B-Cell_Lymphoma/22437814","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22437814.v1","doi":"https://doi.org/10.1158/1078-0432.22437814.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22437814.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_S1-S11_from_Safety_and_Efficacy_of_Axicabtagene_Ciloleucel_versus_Standard_of_Care_in_Patients_65_Years_of_Age_or_Older_with_Relapsed_Refractory_Large_B-Cell_Lymphoma/22437814/1/files/39887215.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362425309.pdf","grobid_xml":"https://content.openalex.org/works/W4362425309.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W2082708772","https://openalex.org/W2107925822"],"related_works":["https://openalex.org/W1966504330","https://openalex.org/W1979139803","https://openalex.org/W2037631372","https://openalex.org/W2030889776","https://openalex.org/W2159000141","https://openalex.org/W1974041167","https://openalex.org/W2391409986","https://openalex.org/W1978297557","https://openalex.org/W1966775726","https://openalex.org/W2140569197"],"abstract_inverted_index":{"Tabulated":[0],"data":[1],"supporting":[2],"ZUMA-7":[3,37],"elderly":[4],"analysis":[5,90,150,175],"Supplementary":[6,12,20,38,53,76,92,113,130,143,155],"Table":[7,13,21,39,54,77,93,114,131,144,156],"S1.":[8],"Patient-reported":[9],"outcomes":[10,28,172],"instruments":[11],"S2.":[14],"Axi-cel":[15],"delivery":[16],"and":[17,26,82,123,136],"administration":[18],"time":[19],"S3.":[22],"Summary":[23,56,95],"of":[24,57,67,96],"efficacy":[25],"safety":[27],"in":[29,36,44,49,72,80,99,106,126,134,151,165,177],"patients":[30,35,48,50,73,86,100,127,140,152,178],"\u226565":[31,51,74,87,104,153,179],"years":[32,52,75,88,102,105,129,142,154,180],"versus":[33,103],"all":[34],"S4.":[40],"Serious":[41],"adverse":[42,118],"events":[43,125],"at":[45],"least":[46],"3":[47],"S5.":[55],"cytopenias":[58],"present":[59],"on":[60,70],"or":[61],"after":[62],"90":[63],"days":[64],"from":[65,167],"initiation":[66],"definitive":[68],"therapy":[69],"protocol":[71],"S6.":[78],"Deaths":[79,133],"axi-cel":[81,108,135],"SOC":[83,137],"arms":[84,138],"for":[85,139,148,169],"(safety":[89],"set)":[91,176],"S7.":[94],"serum":[97],"analytes":[98],"<65":[101],"the":[107],"arm":[109],"(N":[110],"=":[111],"170)":[112],"S8.":[115],"Most":[116],"common":[117],"events,":[119],"cytokine":[120],"release":[121],"syndrome,":[122],"neurologic":[124],"\u226570":[128,141],"S9.":[132],"S10.":[145],"Baseline":[146],"characteristics":[147],"quality-of-life":[149],"S11.":[157],"Mixed":[158],"model":[159],"with":[160],"repeated":[161],"measures":[162,173],"estimated":[163],"difference":[164],"change":[166],"baseline":[168],"prespecified":[170],"patient-reported":[171],"(quality-of-life":[174]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}